BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 31688595)

  • 1. Investigation of Fluorodeoxyglucose Positron Emission Tomography for the Diagnosis of Solid Pseudopapillary Neoplasm of the Pancreas: A Study Associated With a National Survey of Solid Pseudopapillary Neoplasms.
    Kurihara K; Hanada K; Serikawa M; Ishii Y; Tsuboi T; Kawamura R; Sekitou T; Nakamura S; Mori T; Hirano T; Ikemoto J; Chayama K
    Pancreas; 2019; 48(10):1312-1320. PubMed ID: 31688595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperaccumulation of (18)F-FDG in order to differentiate solid pseudopapillary tumors from adenocarcinomas and from neuroendocrine pancreatic tumors and review of the literature.
    Guan ZW; Xu BX; Wang RM; Sun L; Tian JH
    Hell J Nucl Med; 2013; 16(2):97-102. PubMed ID: 23687644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 18F-fluorodeoxyglucose positron emission tomography/computed tomography and the relationship between fluorodeoxyglucose uptake and the expression of hypoxia-inducible factor-1α, glucose transporter-1 and vascular endothelial growth factor in thymic epithelial tumours.
    Toba H; Kondo K; Sadohara Y; Otsuka H; Morimoto M; Kajiura K; Nakagawa Y; Yoshida M; Kawakami Y; Takizawa H; Kenzaki K; Sakiyama S; Bando Y; Tangoku A
    Eur J Cardiothorac Surg; 2013 Aug; 44(2):e105-12. PubMed ID: 23674658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical correlations with (18)FDG PET scan patterns in solid pseudopapillary tumors of the pancreas: still a surgical enigma?
    Kang CM; Cho A; Kim H; Chung YE; Hwang HK; Choi SH; Lee WJ
    Pancreatology; 2014; 14(6):515-23. PubMed ID: 25256437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maximum standardized uptake value on 18F-fluoro-2-deoxy-glucose positron emission tomography/computed tomography and glucose transporter-1 expression correlates with survival in invasive ductal carcinoma of the pancreas.
    Kitasato Y; Yasunaga M; Okuda K; Kinoshita H; Tanaka H; Okabe Y; Kawahara A; Kage M; Kaida H; Ishibashi M
    Pancreas; 2014 Oct; 43(7):1060-5. PubMed ID: 25121413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of a solid pseudopapillary tumor of the pancreas with F-18 FDG positron emission tomography.
    Lee JK; Tyan YS
    Clin Nucl Med; 2005 Mar; 30(3):187-8. PubMed ID: 15722825
    [No Abstract]   [Full Text] [Related]  

  • 7. TFE3 is a diagnostic marker for solid pseudopapillary neoplasms of the pancreas.
    Jiang Y; Xie J; Wang B; Mu Y; Liu P
    Hum Pathol; 2018 Nov; 81():166-175. PubMed ID: 30030118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of F-18-FDG PET/CT findings between pancreatic solid pseudopapillary tumor and pancreatic ductal adenocarcinoma.
    Kim YI; Kim SK; Paeng JC; Lee HY
    Eur J Radiol; 2014 Jan; 83(1):231-5. PubMed ID: 24290142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in the characterization of pancreatic masses: experience from tropics.
    Santhosh S; Mittal BR; Bhasin D; Srinivasan R; Rana S; Das A; Nada R; Bhattacharya A; Gupta R; Kapoor R
    J Gastroenterol Hepatol; 2013 Feb; 28(2):255-61. PubMed ID: 23278193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. F-18 fluorodeoxyglucose uptake in a solid pseudopapillary tumor of the pancreas mimicking malignancy.
    Shimada K; Nakamoto Y; Isoda H; Maetani Y; Yamashita R; Arizono S; Hirokawa Y; Nitta T; Doi R; Haga H; Togashi K
    Clin Nucl Med; 2008 Nov; 33(11):766-8. PubMed ID: 18936608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SUVmax of FDG-PET correlates with the effects of neoadjuvant chemoradiotherapy for oral squamous cell carcinoma.
    Miyawaki A; Ikeda R; Hijioka H; Ishida T; Ushiyama M; Nozoe E; Nakamura N
    Oncol Rep; 2010 May; 23(5):1205-12. PubMed ID: 20372831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The usefulness of lymphoid enhancer-binding factor 1 and androgen receptor in diagnosing solid pseudopapillary neoplasm of the pancreas on cytopathology.
    McHugh KE; Stelow EB; Harrison GP; Policarpio-Nicolas MLC
    Cancer Cytopathol; 2019 Nov; 127(11):700-707. PubMed ID: 31584754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography in differential diagnosis of benign and malignant intraductal papillary-mucinous neoplasm of the pancreas.
    Tomimaru Y; Takeda Y; Tatsumi M; Kim T; Kobayashi S; Marubashi S; Eguchi H; Tanemura M; Kitagawa T; Nagano H; Umeshita K; Wakasa K; Doki Y; Mori M
    Oncol Rep; 2010 Sep; 24(3):613-20. PubMed ID: 20664965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical role of fludeoxyglucose (18F) positron emission tomography/computed tomography (
    Matsumoto T; Okabe H; Yamashita YI; Yusa T; Itoyama R; Nakao Y; Yamao T; Umzaki N; Tsukamoto M; Kitano Y; Miyata T; Arima K; Nitta H; Hayashi H; Imai K; Chikamoto A; Baba H
    Surg Today; 2019 Jan; 49(1):21-26. PubMed ID: 30128759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical utility of 2-[(18)F] fluoro-2-deoxy-D-glucose positron emission tomography in predicting World Health Organization grade in pancreatic neuroendocrine tumors.
    Tomimaru Y; Eguchi H; Tatsumi M; Kim T; Hama N; Wada H; Kawamoto K; Kobayashi S; Morii E; Mori M; Doki Y; Nagano H
    Surgery; 2015 Feb; 157(2):269-76. PubMed ID: 25311263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of cytomorphology in distinguishing solid pseudopapillary neoplasm of pancreas from pancreatic neuroendocrine tumor with emphasis on nuclear folds and nuclear grooves.
    Misra S; Saran RK; Srivastava S; Barman S; Dahale A
    Diagn Cytopathol; 2019 Jun; 47(6):531-540. PubMed ID: 30677247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FDG PET/CT findings of solid pseudopapillary tumor of the pancreas with CT and MRI correlation.
    Dong A; Wang Y; Dong H; Zhang J; Cheng C; Zuo C
    Clin Nucl Med; 2013 Mar; 38(3):e118-24. PubMed ID: 23354028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of preoperative fluorodeoxyglucose positron emission tomography/computed tomography in patients with potentially resectable pancreatic cancer.
    Omiya Y; Ichikawa S; Satoh Y; Motosugi U; Nakajima N; Onishi H
    Abdom Radiol (NY); 2018 Dec; 43(12):3381-3389. PubMed ID: 30043215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrast-enhanced fluorodeoxyglucose positron emission tomography/computed tomography in solid pseudopapillary neoplasm of the pancreas.
    Santhosh S; Lakshmanan RK; Sonik B; Padmavathy R; Gunaseelan RE
    Indian J Nucl Med; 2016; 31(2):131-3. PubMed ID: 27095862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solid-pseudopapillary neoplasm of the pancreas: awareness of unusual clinical presentations and morphology of the clear cell variant can prevent diagnostic errors.
    Zhao P; deBrito P; Ozdemirli M; Sidawy MK
    Diagn Cytopathol; 2013 Oct; 41(10):889-95. PubMed ID: 23584981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.